International Journal of Clinical Research

Objective: To study the effect of rilalutide combined with metformin in the treatment of diabetes. Methods: 80 patients with diabetes in our hospital were selected as the subjects of this study and divided into two groups (control group and experimental group) according to the computer table method. The patients in the control group were treated with metformin, while the patients in the experimental group were treated with liraglutide on the basis of the control group. The clinical treatment effect, adverse reactions, related blood glucose index levels, and adipose factor levels of the two groups were compared. Results: The total effective rate of clinical treatment in the experimental group was higher than that in the control group, and the incidence of adverse reactions was lower than that in the control group. The levels of related blood glucose indicators and adipose factors in the experimental group were better than those in the control group, with differences between the groups (P<0.05). Conclusion: For patients with diabetes, the combination of rilalutide and metformin has a significant effect, reduces the occurrence of adverse reactions, has high drug safety, improves relevant indicators, and is worth popularizing.

Lilalutide; Metformin; Diabetes; treatment effect